Risk of progression and the cause of mortality at chronic viral mixed-hepatitis by K. I. Yesmembetov, D. T. Abdurakhmanov, A. V. Odintsov, N. A. Mukhin

Subjects: Get full text

An algorithm for infectious screening of corneal donors in eye tissue bank of the Fyodorov Eye Microsurgery Federal State Institution by S.A. Borzenok, M.Yu. Gerasimov, Yu.A. Komakh, M.Kh. Khubetsova, H.D. Tonaeva, L.M. Malikova, P.I. Plaksa

Subjects: Get full text

Research progress of drug-related adverse reactions in hepatitis C patients and related nursing interventions (丙肝患者药物相关性不良反应及护理干预的研究进展) by ZHANG Xiaoning (张晓宁), WANG Xinhua (王新华), CHEN Ying (陈英)

Subjects: “…hepatitis c…”
Get full text

Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy by Curtis Cooper, Stephen Shafran, Susan Greenbloom, Robert Enns, John Farley, Nir Hilzenrat, Kurt Williams, Magdy Elkashab, Nabil Abadir, Manuela Neuman

“…BACKGROUND: Serum tumour necrosis factor-alpha (TNF-α) levels correlate negatively with hepatitis C virus (HCV) antiviral response.…”
Get full text

Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment by M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin

Subjects: Get full text

Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) by Robert P Myers, Curtis Cooper, Morris Sherman, Richard Lalonde, Helga Witt-Sullivan, Magdy Elkashab, Paul Harris, Rob Balshaw, Christopher Usaty, Paul J Marotta

“…BACKGROUND: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic or community centres.…”
Get full text

A 7-Amino Acid Peptide Mimic from Hepatitis C Virus Hypervariable Region 1 Inhibits Mouse Lung Th9 Cell Differentiation by Blocking CD81 Signaling during Allergic Lung Inflammation by Wanzhou Zhao, Conghao Tan, Xi Yu, Ruihe Yu, Qibing Mei, Yun Cheng

“…A 7-amino acid peptide (7P) of the hypervariable region 1 (HVR1) of hepatitis C virus has been identified as an important regulator in the type 2 cytokine (IL-4, IL-5, and IL-13) immune response. …”
Get full text

Observational pilot using a Data to Care intervention strategy to promote HCV re-engagement and cure for persons with HIV/HCV co-infection who are out of care by Maximilian Wegener, Deborah Gosselin, Ralph Brooks, Suzanne Speers, Merceditas Villanueva

Subjects: “…Hepatitis C virus (HCV)…”
Get full text

Acute kidney injury and ANCA positivity in a patient treated with glecaprevir/pibrentasvir: a case report by Lawrence Hyun Kwon, Jennifer Griffiths, Lanny DiFranza

Subjects: Get full text

Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies by Bing Liu, Shishi Feng, Xuan Guo, Jing Zhang

Subjects: Get full text

Telaprevir: options of application in separate patient groups by M. V. Mayevskaya, I. N. Tikhonov, V. T. Ivashkin

Subjects: Get full text

Traditional Chinese Medicine nursing for patients with skin rash caused by pegylated interferon α-2a combined with ribavirin therapy of chronic viral hepatitis C (慢性丙型肝炎患者聚乙二醇干扰素α-2a联合利巴韦林抗病毒治疗所致皮疹的中医护理体会) by LI Hongyan (李红艳), WANG Xiaojun (汪晓军), ZHANG Lili (张莉莉)

“…This paper analyzed the clinical data of 5 patients with skin rash caused by pegylated interferon α-2a combined with ribavirin therapy of chronic viral hepatitis C. According to the clinical symptoms, patients were given internal administration of Chinese herbal medicine decoction combined with external wash of Chinese herbal medicine decoction. …”
Get full text

Achieving chronic hepatitis B functional cure: Factors and potential mechanisms by Jiarui Zheng, Zilong Wang, Linxiang Huang, Zixuan Qiu, Yandi Xie, Suzhen Jiang, Bo Feng

Get full text

The theses for MD degree by article Editorial

“…Abdullayev – Clinical value of polymorphism of cytokine genes and hemochromatosis gene at chronic hepatitis C patients.S.A. Abdullayev – Clinical value of polymorphism of cytokine genes and hemochromatosis gene at chronic hepatitis C patients.…”
Get full text

The Management of Chronic Viral Hepatitis: A Canadian Consensus Conference 2004 by Morris Sherman, Vincent Bain, Jean-Pierre Villeneuve, Robert P Myers, Curtis Cooper, Steven Martin, Catherine Lowe

“…There were also recommendations on the investigation and treatment of chronic hepatitis C and hepatitis C-HIV coinfection. In addition, the document makes some recommendations about the provision of services by provincial governments to facilitate the delivery of care to patients with hepatitis virus infection. …”
Get full text

Efficacy of daclatasvir and asunaprevir for viral hepatitis С in two donor lung recipients by D. T. Abdurakhmanov, Ye. . Sidorova, I. N. Tikhonov, N. A. Mukhin, V. T. Ivashkin

“…To estimate efficacy and safety of direct antiviral drugs for hepatitis C treatment in donor lung recipients. Key points. …”
Get full text

Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients by Yu-Xuan Song, Guang-Jun Song, Hui Ma, Bo Feng, Yan-Di Xie

Get full text

A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal by Corry van den Bosch

“…The mechanisms of oncogenesis believed to operate in Hepatitis C lymphomagenesis are discussed, as is their potential applicability to Chikungunya Virus.…”
Get full text

Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide by Rui Huang, Chunli Zhang, Xiaodong Mo, Huiying Rao, Rongman Jia

Get full text

Appropriateness of Liver Biopsy by Thierry Poynard, Vlad Ratziu, Pierre Bedossa

“…This review aims to discuss the appropriateness of liver biopsy in two frequent liver diseases, hepatitis C and alcoholic liver disease. The medical literature, published between 1965 and 1999, was reviewed by using MEDLINE. …”
Get full text